Aug. 20 at 12:27 PM
$ICCM is moving on clinical trial results following a PR Newswire release.
IceCure Medical received IRB approval to commence the ChoICE post-marketing study evaluating ProSense cryoablation for breast cancer treatment in patients aged 70 and older.
RTPR pushed this release out to users at 8:10:00 AM ET